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Abstract
Background: Pain is the most common reason that patients present to an emergency department (ED) and is
often inadequately managed. Evidence suggests that acupuncture is effective for pain relief, yet it is rarely
practiced in the ED. The current study aims to assess the efficacy of acupuncture for providing effective analgesia
to patients presenting with acute low back pain, migraine and ankle sprain at the EDs of four hospitals in
Melbourne, Australia.
Method: The study is a multi-site, randomized, assessor-blinded, controlled trial of acupuncture analgesia in
patients who present to an ED with low back pain, migraine or ankle sprain. Patients will be block randomized to
receive either acupuncture alone, acupuncture as an adjunct to pharmacotherapy or pharmacotherapy alone.
Acupuncture will be applied according to Standards for Reporting Interventions in Clinical Trials of Acupuncture
(STRICTA). Pain after one hour, measured using a visual analogue scale (VAS), is the primary outcome. Secondary
outcomes measures include the following instruments; the Oswestry low back pain disability questionnaire, 24-hour
Migraine Quality of Life questionnaire and Patient’s Global Assessment of Ankle Injury Scale. These measures will be
recorded at baseline, 1 hour after intervention, each hour until discharge and 48 ± 12 hours of ED discharge. Data
will also be collected on the safety and acceptability of acupuncture and health resource utilization.
Discussion: The results of this study will determine if acupuncture, alone or as an adjunct to pharmacotherapy
provides effective, safe and acceptable pain relief for patients presenting to EDs with acute back pain, migraine or
ankle sprain. The results will also identify the impact that acupuncture treatment may have upon health resource
utilisation in the ED setting.
Trial registration: Australia and New Zealand Clinical Trials Register (ANZCTR): ACTRN12609000989246
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Background
There is evidence that pain is often inadequately mana-
ged in emergency settings [1,2]. Emergency department
(ED) staff is constantly under pressure to assess, treat
and admit or discharge patients within strict time con-
straints despite having little or no control over patient
influx [1-3]. Hence, additional therapy that could
provide safe and effective pain relief, shorten ED length
of stay, and avoid patient admission would be
advantageous.
Since 1984, acupuncture has been reimbursed by the
Australian National health System under the Medicare
Benefits Scheme (MBS) (items 173, 193, 195, 197 and
199). In the 2009/2010 financial year, there were a total
of 537,785 acupuncture services reimbursed by Medicare
at a cost of $ 21,143,968. Of these services, only 49 were
delivered within hospitals at a cost of $ 1,821 [4]. The
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ture use suggests that acupuncture is under-utilised in
hospital settings.
Acupuncture research
Amongst Australian general practitioners (GPs), acu-
puncture is one of the most accepted forms of comple-
mentary medicine [5]. In 1998, a United States National
Institute of Health Consensus Conference Panel
reviewed the status of acupuncture and concluded that:
“There is sufficient evidence of acupuncture’s value to
expand its use into conventional medicine and to encou-
rage further studies of its physiology and clinical
value.”[6] Similarly, in 2002, the World Health Organi-
sation (WHO) stated that acupuncture is a safe, simple
and convenient therapy and that its effectiveness as
analgesia has been established in controlled clinical
studies.
While the literature on the physiological effects and
mechanisms of acupuncture analgesia is extensive, the
clinical literature is of poorer quality [2,6,7]. Most
reports have methodological flaws including poor study
design, inadequate statistical analysis, difficulties in diag-
nosis definition, unsuitable placebo or sham interven-
tions and control groups, and a lack of funding, or
qualified researchers with access to clinical settings [7,8].
Notwithstanding these difficulties, it has been shown
that acupuncture analgesia in the treatment of chronic
pain is comparable to morphine and that its better
safety profile and lack of dependence makes it the pre-
ferred method of choice for these conditions [9].
Also, the publication of the Standards for Reporting
Interventions in Controlled Trials of Acupuncture
(STRICTA) guidelines in 2002[10] has resulted in a dra-
matic improvement in the precision of reporting of acu-
puncture interventions [11].
There are very few clinical trials of acupuncture for
acute pain to inform clinical practice [7]. When review-
ing the evidence for the use of acupuncture in acute set-
tings, only two published randomized controlled trial of
acupuncture in an ED setting could be located in the
peer-reviewed literature [12,13]. One study found a sig-
nificantly greater reduction in pain in the group receiv-
ing acupuncture and standard therapy, compared to the
group receiving standard therapy alone [12]. The other
found that the use of concomitant auricular and electri-
cal acupuncture, when implemented early in acute
spinal cord injury, can contribute to significant neurolo-
gic and functional recoveries [13]. Although these stu-
dies describe the acupuncture treatment protocol and
utilised some blinding (blinding of assessors) they did
not examine the effect on length of stay (ED and hospi-
tal), applicability or acceptability of acupuncture.
As of June 2011, virtually all of the 31 reviews and 32
review protocols listed in the Cochrane library suggest
that the evidence for acupuncture is inconclusive. Con-
sequently, there has been a call for the funding of well-
planned, large-scale studies to assess the effectiveness
and cost-effectiveness of acupuncture under real-life
conditions [14]. It has been suggested that the best
methodological approach to clinical acupuncture
research is through pragmatic trials where acupuncture
is compared to standard care rather than placebo-con-
t r o l l e dt r i a l s .S u c ht r i a l sm a yb em o r ea b l et op r o v i d e
data that is relevant to patients, practitioners and policy-
makers, and to inform decision-making about treatment
options [15].
Aims
The primary aim of this research is to determine
whether acupuncture is effective, safe and acceptable for
patients presenting to the ED with low back pain,
migraine or acute ankle injuries. The impact on health
resource utilisation will also be explored.
Methods
This project comprises a suite of multicentre, pragmatic,
single-blinded, randomised, and controlled clinical trials.
They will compare the effects of acupuncture alone,
pharmacotherapy alone and acupuncture/pharmacother-
apy combined for the three conditions of interest (ankle
sprain, migraine or lower back pain).
The trial is registered with The Australian New Zeal-
and Clinical Trial registry and received approval from
the ethics committees of RMIT University, as well as
the participating hospitals.
Population
Patients will be recruited through the EDs of four large
tertiary teaching hospitals in Melbourne, Australia.
These include two public EDs (The Northern Hospital
and the Alfred Hospital Emergency and Trauma Centre)
and two private EDs (The Epworth and Cabrini Hospi-
tals). Participants will be recruited over a period of
approximately 24 months with a target sample size of
505 subjects.
Inclusion Criteria
Patients aged ≥ 18 years and who require analgesia for
one of the following conditions will be considered for
enrolment:
1) Low back pain: all patients with either acute or
acute-on-chronic low back pain, with or without
referred pain. For the purposes of the study, acute low
back pain is defined as pain of less than 3 months dura-
tion [16]
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the International Headache Society [17].
3) Acute ankle injuries: all patients with an acute ankle
injury within 72 hours of presentation.
General Exclusion Criteria
Patients will be excluded from all three studies if any of
the following is applicable:
1) temperature > 37.7°C[18]
2) acute major trauma, such as falls from a height or
road traffic accidents
3) anticoagulation medication use or the presence of a
mechanical heart valve
4) skin infections that would preclude certain acu-
puncture points being used
5) signs of illness that the treating physician feels will
make them inappropriate for acupuncture or
pharmacotherapy
6) refusal, inability to consent or communication
difficulties
7) any form of analgesia up to 60 minutes prior to t0
(study commencement)
8) an initial pain score ≤ 4o nt h ep a i ns c a l e( s c o r e
range 0-10)
9) presentation to the ED > 4 times in the previous 3
months with the same condition
Specific Exclusion Criteria
1) Low back pain trial: any suspected non-musculoske-
letal cause for the back pain and suspected vertebral
fracture.
2) Migraine trial: any suspected condition not consis-
tent with the definition of migraine
3) Acute ankle injury trial: obvious deformity sugges-
tive of ankle dislocation or fracture.
An ED physician will assess each patient and, if they
meet the study entrance criteria, informed consent will
be obtained. The patient will then be randomised to
either acupuncture, pharmacotherapy or acupuncture/
pharmacotherapy combined.
Interventions
Acupuncture Alone
The acupuncturists will be either a qualified Traditional
Chinese Medicine TCM practitioner registered with the
Chinese Medicine Registration Board of Victoria or an
ED physician with medical acupuncture qualifications
accredited with the Royal Australian College of General
Practitioners and the Australian Medical Acupuncture
College (RACGP-AMAC) Joint Consultative Committee
on Medical Acupuncture.
Treatment protocols were determined through review
of major clinical manuals and textbooks, literature
review, and a panel of specialist acupuncturists from
both western medicine and Chinese medicine back-
grounds. The protocols, which allow acupuncture points
to be selected from a pool of pre-determined points for
each condition, provide sufficient standardisation to
assist replication, yet are flexible enough to allow indivi-
dualised treatments (Table 1). These protocols also
allow for additional points, such as ‘ashi points’,t ob e
used at the discretion of the acupuncturist. The location
of the points, angle of insertion and depth of insertion
were sourced from a popular text ‘AM a n u a lo fA c u -
puncture’ [19].
Pharmacotherapy Alone
Patients in the pharmacotherapy group will receive
treatment as per standard practice within each ED and
good clinical practice guidelines. These are based on
guidelines from the National Institute of Clinical Studies
(NICS) and National Health and Medical Research
Council (NHMRC) for migraine [20,21] and NHMRC
for low back pain and ankle injuries [22].
From an expert panel of emergency physicians, a drug
therapy protocol was developed based on the most com-
monly administered analgesics. While comprising 1st
and 2nd line drugs, it was recognized that while patients
should be treated with one of the drugs from the proto-
c o l ,o t h e rd r u g sm a yb ea d m inistered at the treating
physicians’ discretion. This may occur in cases of known
drug allergy, previous efficacy of other drugs for the
individual or personal preference of the physician (Table
2).
Combined treatment
Patients in the combined therapy group will be adminis-
tered both acupuncture and pharmacotherapy, as
described above. In order to maintain acupuncturist
blinding, the acupuncture will be either administered
before or after the pharmacotherapy rather than concur-
rently. After one treatment has commenced an allow-
ance of up to 15 minutes will be permitted for the
second treatment to follow. Administering the second
treatment outside the 15 minutes will be considered a
violation of protocol and the data will be excluded.
Specific treatments
As the mainstay of immediate treatment for acute ankle
injuries is rest, ice, compression and elevation (R.I.C.E.),
all ankle sprain patients will receive this management
regardless of their randomisation status. Similarly, as
vomiting and potential dehydration is a common feature
of patients presenting with migraine, migraine patients
will receive intravenous fluids at the treating physicians’
discretion, regardless of their randomization status. Res-
cue therapy (pharmacotherapy or acupuncture) will be
allowed for patients with inadequate pain relief after 1
hour (t1), or earlier if the treating physician advises.
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Local points Distal points Other Stimulation Needle
choice and
Retention
Time
All three
Conditions
LI4 and LV3 Hwato 0.22
×1 3m m
Hwato0.25
×3 0m m
Hwato0.25
×4 0m m
Seirin 0.25
×3 0m m
20-30
minutes
retention
Lower
Back Pain:
Central
type
Huatoujiaji,
DU3 and DU4,
BL 29, BL30,
BL31 and BL32
GB 30, BL40, BL54, BL 58, BL62, and KI 3 Other
points-
Ashi points
as suitable
- Local and Ashi points should be
stimulated gently til Deqi is achieved or in
the case of a trigger point where a twitch
response is elicited.
Lower
Back Pain:
Lateral
Type
BL23, BL25,
BL52, BL54
and Yaoyan
GB 30, BL40, BL54, BL 58, BL62, and KI 3 Other
points-
Ashi points
as suitable
- Distal points stimulated more strongly and
using a reduction technique
Ankle
Sprain
Local points
should be
selected from
ST41, GB40,
BL60, BL 62, BL
63 or
64 KI2, KI3, KI6,
SP4, SP5
Distal points SP6, SP9, GB34, ST36 (use with
caution on patients with low blood
pressure) and HT7 on the opposite wrist to
the injury
Other
points-
Ashi points
as suitable
- Local and Ashi points should have no or
very little stimulation
- Distal points are to be stimulated more
strongly using a reduction technique
Migraine -Minimal local
point selection
(1-2 points)
from Taiyang,
ST8, GB8,
DU23, BL10, BL
11, GB2
and GB14
according to
pain location.
If significant
retro-orbital
pain: BL2
-Distal points use LV3, LV 2, GB34, LI4, SJ5,
ST 36, ST44, BL60, GB41, SP6
Nausea/
vomiting
add, GV18,
PC6 or ST40
Other
points-
Ashi points
as suitable
-Local points should be no/minimal
stimulation
-Distal points should use a reduction
technique
Table 2 Pharmacotherapy selection protocol
1st line therapy options: Ankle
sprain
Lower back
pain
Migraine
X
3centerHartmans5% DextroseNaCl 0.9% X X X
metaclopramide 10-20 mg IV or prochlorperazine 12.5 mg IM, if there is significant nausea and
vomiting.
X
paracetamol 1 g XX X
paracetamol with codeine XX X
Tramadol 50-100 mg XX X
dextropropoxphene and paracetamol X X X
ibuprofen OR diclofenac OR indomethicin X X X
2
nd line therapy options:
> 1 hour (t1)
Ankle
sprain
Lower back
pain
Migraine
Morphine 2.5 mg IV boluses XX X
Chlorpromazine: 25 mg in 1000 ml normal saline IV X
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Randomisation will be undertaken by an independent
statistician using a computerized software randomization
program. Each condition and site will be stratified and
block randomised, respectively, with the treatment allo-
cation concealed in sealed opaque envelopes. These
envelopes will be stored at each site in a locked filing
cabinet, until the researcher has screened the patient for
inclusion and gained signed informed consent. At this
time, the next envelope in sequence will be accessed
and opened by the triage nurse (not the researcher).
As this is a pragmatic trial, participants will not be
blinded to their treatment allocation [23]. However, the
study will be single-blinded such that the researcher
performing outcome measure assessments will be
blinded to the patient’s treatment allocation. Further-
more, the acupuncturist will be blinded as to whether
the patient is also receiving pharmacotherapy.
Data collection
Data will be collected hourly from baseline (t0, t1, t2,
etc) and at discharge unless data was collected within
the 20 minutes of discharge. A telephone follow-up will
be conducted within 48 ± 12 hours of ED discharge, by
a researcher blinded to the participant’s treatment allo-
cation. (Table 3)Participation in the study will end at
any stage if the patient refuses to continue or in the pre-
sence of significant clinical deterioration, as determined
by the attending ED physician. For those participants
who are lost to follow up or drop out, after t1 data has
been collected, intention to treat analysis will be applied
to the existing data.
Primary Outcome Measures
1) Pain
Pain (at rest) will be assessed using a Verbal Numer-
ical Rating Scale (VNRS) out of 10 (0 = no pain, 10
= worst pain imaginable) [24].
The three treatment groups will be compared as a
function of the proportion of patients
who have clinically significant pain score reductions,
as follows:
a. to < 4/10 (mild pain)
b. of > 2/10 (a clinically significant pain reduction)
Secondary Outcome Measures
1) Functionality:
a. Back pain: Oswestry low back pain disability ques-
tionnaire [25].
b. Migraine: 24-hour Migraine Quality of Life ques-
tionnaire [26].
c. Acute ankle injuries: Patient’s Global Assessment
of Ankle Injury Scale [27].
2) Adverse events:
a. Nausea, dizziness, drowsiness, fatigue, rashes,
visual disturbance, constipation, abdominal pain, and
other adverse events using a rated 0-10 (no impair-
ment - intolerable)
c. Vomiting: documenting the number of times vom-
ited since last assessment
d. local complications of acupuncture; bleeding,
bruising or other complication
3) Acceptability: will be assessed at t1, on leaving the
ED and at 48 hour follow up using the follow instru-
ments:
a. Satisfaction: using an ordinal scale 0-10 (0 = very
dissatisfied, 10 = very satisfied)
b. Willingness to repeat similar management in
future: using a 5 option ordinal scale (definitely no,
probably no, unsure, probably yes, definitely yes).
4) Health Resource Utilization: will be determined
after the 48 hour follow up using the following variables:
a. Length of stay in the ED
Table 3 Data measures
t0 t1 t2 > Discharge 48 ± 12 hours post discharge
Demographics (age, post code, triage category) X
Triage time, time seen by doctor, time of discharge X
Pain scores (at rest, at movement) X X X X X
Signs and symptoms X X X X X
Relative instrument (MQOL, Global Ankle Scale or OSWESTRY) X X X X
Acceptability, willingness to repeat X X X
Complications of acupuncture X X X
Additional medication used and health care utilization X
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c. Admission rate
d. Re-presentation rate
e. Seeking other Health Care Professional advice
after initial presentation.
f. Additional analgesia/pharmacotherapy used after
initial presentation (prescription as well as non-
prescription)
5) Rescue therapy requirements in the ED:
a. At t1
b. At any stage following t1
Safety and Ethics
A Data Safety and Monitoring Committee (DSMC),
independent of the investigators, comprising experts in
clinical trials, biostatistics and acupuncture/emergency
medicine will be established before patient enrolment.
The DSMC will review all trial protocols, monitor
patient safety, investigate any adverse events, and ana-
lyse mid trial results. They will terminate the trial if
there are concerns for participant safety, or if the
interim results indicate that a particular arm of the trial
is clearly superior to the others.
Statistical methods
We performed sample size calculations for each of the
three conditions, i.e., back pain, migraine and ankle
sprain, using both the equivalence (between acupuncture
and pharmacotherapy) and non-inferiority (between
combined and pharmacotherapy) approaches, assuming
t h a tad i f f e r e n c eo f1 . 5u n i t si nV i s u a lA n a l o g u eS c a l e
(VAS) score is clinically relevant. The conservative
equivalence sample size will allow detection of superior-
ity of the combined treatment arm if present.
Standard deviations were estimated from pilot data
obtained from the Northern Hospital. Table 4 was gen-
erated using sample size software (PASS2005; Utah;
USA). It shows the number of participants required per
intervention group (round to the next 5) to achieve 0.8
power at the 0.05 alpha level, after adjusting for an attri-
tion rate of no more than 10%. Hence, the maximum
number of subjects required will not exceed (70 + 60 +
55) × 2 + (35 + 35 +65) = 505. We also conducted a
sensitivity analysis and found that the maximum sample
size will reduce to 360 if the equivalence limit is defined
as 2.0 units of VAS.
Data analysis
Descriptive statistics and 95% confidence intervals will
be reported. Continuous outcome variables, of the
groups at different time points, will be compared using
mixed models with the treatment group as a fixed factor
and time as a random factor. Categorical data will be
analysed using generalized estimating equations (GEE).
While all analyses will be undertaken following the
intention-to-treat principle using imputation techniques,
per-protocol analysis will also be undertaken as a form
of sensitivity analysis. The Sharpened Bonferroni
method will be used to adjust for individual alpha level
when multiple testing is performed. For qualitative data,
we will identify recurring themes and develop a concep-
tual framework to apply to the complete data set. Data
analysis will be conducted by specialist statisticians’
independent from the research team.
Discussion
The results of this research will determine if acupunc-
ture, alone or as an adjunct to pharmacotherapy pro-
vides effective, safe and acceptable pain relief for
patients presenting to EDs with acute back pain,
migraine or ankle sprain. The results will also identify
the impact that acupuncture treatment may have upon
health resource utilisation in the ED setting.
These results could inform revisions of ED clinical
pain management guidelines as well as the training of
emergency physicians and ED staffing on a national and
international level.
The results could also provide consumers with infor-
mation about viable analgesic choices. If acupuncture is
demonstrated to be effective in these conditions, there
may be a number of patients with these conditions who
seek out acupuncture rather than pharmacotherapy.
The research may also have a major impact on future
research for other acute symptoms where acupuncture
is thought to be efficacious.
Table 4 Sample size justification
Testing Power Sample Size Equiv Limit True Diff Standard Deviation
Equivalence Ankle Sprain 0.81 35 1.5 0.0 1.95
Migraine 0.80 35 1.5 0.0 1.96
Low Back Pain 0.80 65 1.5 0.0 2.79
Non-Inferiority Ankle Sprain 0.80 70 1.5 0.0 3.25
Migraine 0.80 60 1.5 0.0 2.98
Low Back Pain 0.81 55 1.5 0.0 2.88
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The trial is currently in recruitment phase.
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